Endpoints News ١٨ فبراير ٢٠٢٦ Charles River highlights increase in demand as tariff uncertainties fade
Endpoints News ١٨ فبراير ٢٠٢٦ Novartis signs macrocyclic deal with Unnatural Products for $100M upfront
Endpoints News ١٨ فبراير ٢٠٢٦ Reversal on Moderna's flu application follows atypical path through FDA
Endpoints News ١٨ فبراير ٢٠٢٦ Lilly's Zepbound, Taltz combo data in psoriasis and weight loss; Novartis bolsters Rhapsido results
Endpoints News ١٨ فبراير ٢٠٢٦ Lilly licenses CSL’s IL-6 immuno-inflammatory antibody for $100M upfront
Endpoints News ١٧ فبراير ٢٠٢٦ FDA rejects Disc Medicine's rare disease drug despite granting it a commissioner voucher